Log in or Sign up for Free to view tailored content for your specialty!
Psoriatic Arthritis News
HAQ-DI, PROMIS-PF highly agreeable in psoriatic arthritis
The Health Assessment Questionnaire-Disability Index and the Patient-Reported Outcomes Measurement Information System-Physical Function had excellent agreement in finding psoriatic arthritis minimal disease activity, according to findings.
COVID-19 outcomes worse in patients with inflammatory arthritis receiving glucocorticoids
COVID-19 outcomes are worse among patients with inflammatory arthritis receiving glucocorticoids, but not in those receiving anticytokine therapy, according to data published in Arthritis & Rheumatology.
Log in or Sign up for Free to view tailored content for your specialty!
Dermatologist: Keep these three topical steroids 'in your back pocket'
Common “pitfalls” among rheumatologists when prescribing topical steroids include doses that are too weak or low in volume, and a failure to advise patients on side effects, said a speaker at the 2020 Congress of Clinical Rheumatology-East.
Combination therapy, personalized medicine on the horizon in psoriatic arthritis
There is much to look forward to in the management of psoriatic arthritis, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.
Checkpoint induced arthritis severely impacts QoL for patients with cancer
Patients with immune checkpoint therapy-induced inflammatory arthritis report significant social, functional and emotional impacts, compared with cancer and other side effects, according to findings published in BMC Rheumatology.
Risk for COVID-19 varies by rheumatic disease, age, prior therapy use
The risk for hospital-diagnosed COVID-19 among patients with autoimmune or immune-mediated disease may depend on age, specific disease and prior therapy, according to data published in the Annals of the Rheumatic Diseases.
Radiographic Inhibition and PsA
This episode investigates the history of how psoriatic arthritis became recognized as a distinct disease. Then explores the bone changes and radiographic findings of PsA.
Ixekizumab outperforms adalimumab for joint, skin improvement in PsA
Ixekizumab demonstrated significantly greater joint and skin improvement, through week 52, than adalimumab among patients with psoriatic arthritis, according to data published in the Annals of the Rheumatic Diseases.
Q&A: Psoriasis Awareness Month a time to educate, learn
August marks Psoriasis Awareness Month, a time to spread information about the disease and its treatment options, as well as to support those who experience its manifestations.
Deeper disease insight signals 'exciting time' for PsA drug pipeline
Patients with psoriatic arthritis have much to be hopeful about, with understanding of the disease increasing and an expanded range of treatment options available, according to a presenter at the 2020 Rheumatology Nurses Society Annual Conference.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read